Immunogenicity and safety of recombinant novel coronavirus vaccine (CHO cell) after two doses of inactivated SARS-CoV-2 vaccine in healthy adults

ZHANG Shang-xiao; YANG Shi-long; HUANG Tao; ZHONG Zai-xin; ZHAO Jun-shi; LI Xu; DAI De-fang; HU Chun-sheng; SUN Jiu-feng; GAO Li-dong

doi:10.3969/j.issn.1006-3110.2022.04.001

ZHANG Shang-xiao, YANG Shi-long, HUANG Tao, ZHONG Zai-xin, ZHAO Jun-shi, LI Xu, DAI De-fang, HU Chun-sheng, SUN Jiu-feng, GAO Li-dong

Practical Preventive Medicine ›› 2022, Vol. 29 ›› Issue (4) : 385-389.

PDF(746 KB)

Practical Preventive Medicine ›› 2022, Vol. 29 ›› Issue (4) : 385-389. DOI: 10.3969/j.issn.1006-3110.2022.04.001

Special Report—COVID-19 Prevention and Treatment

Immunogenicity and safety of recombinant novel coronavirus vaccine (CHO cell) after two doses of inactivated SARS-CoV-2 vaccine in healthy adults

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 29(4): 385-389 https://doi.org/10.3969/j.issn.1006-3110.2022.04.001

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(746 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2021-12-19	2022-04-15
Issue Date
2022-04-26

Please choose a citation manager

Content to export